Valuation Torrent Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 10:20:21 11/11/2026 GMT			5-day change	1st Jan Change
4,763.00 ^INR	-0.25%		+2.76%	+23.98%

10-23	Torrent Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI
10-23	Torrent Pharmaceuticals Limited, Q2 2027 Earnings Call, Oct 23, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	473,197	520,309	880,347	1,094,736	1,428,460	1,811,692	-	-
Change	-	9.96%	69.2%	24.35%	30.48%	26.83%	-	-
Enterprise Value (EV) ¹	508,027	566,719	910,767	1,119,846	1,564,790	1,935,130	1,904,627	1,864,624
Change	-	11.55%	60.71%	22.96%	39.73%	23.67%	-1.58%	-2.1%
P/E	60.9x	57.4x	53.1x	57.3x	66x	73.2x	53x	41.7x
PBR	7.95x	8.4x	12.8x	14.4x	17x	12.9x	10.9x	9.08x
PEG	-	3.4x	0.6x	3.7x	5x	40.93x	1.4x	1.5x
Capitalization / Revenue	5.56x	5.41x	8.21x	9.51x	10.2x	9.07x	8.07x	7.18x
EV / Revenue	5.97x	5.89x	8.49x	9.72x	11.2x	9.69x	8.49x	7.39x
EV / EBITDA	20.9x	19.9x	27x	30.1x	34.3x	28.7x	24.3x	20.7x
EV / EBIT	28.7x	26.5x	34.4x	38.3x	45.5x	44.5x	35.3x	28.7x
EV / FCF	31.8x	31.6x	32.1x	56.7x	66.7x	45.6x	33.5x	29.2x
FCF Yield	3.15%	3.17%	3.11%	1.76%	1.5%	2.19%	2.99%	3.43%
Dividend per Share ²	16.5	22	28	32	38	29.69	34.76	41.82
Rate of return	1.18%	1.43%	1.08%	0.99%	0.9%	0.62%	0.73%	0.88%
EPS ²	22.96	26.79	48.94	56.47	63.92	65.06	89.94	114.3
Distribution rate	71.8%	82.1%	57.2%	56.7%	59.4%	45.6%	38.7%	36.6%
Net sales ¹	85,080	96,200	107,280	115,160	139,800	199,655	224,380	252,223
EBITDA ¹	24,310	28,420	33,680	37,210	45,590	67,504	78,297	90,062
EBIT ¹	17,690	21,350	26,480	29,260	34,400	43,444	53,984	64,995
Net income ¹	7,770	12,450	16,560	19,110	21,630	23,964	33,894	43,676
Net Debt ¹	34,830	46,410	30,420	25,110	136,330	123,438	92,935	52,932
Reference price ²	1,398.15	1,537.35	2,601.15	3,234.60	4,220.65	4,763.00	4,763.00	4,763.00
Nbr of stocks (in thousands)	338,445	338,445	338,445	338,445	338,445	380,368	-	-
Announcement Date	25/05/22	30/05/23	24/05/24	20/05/25	22/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
TORRENT PHARMACEUTICALS LIMITED	73.39x	9.72x	28.73x	0.62%	19.37B
ELI LILLY AND COMPANY	41.91x	14.16x	30.08x	0.48%	1,276B
JOHNSON & JOHNSON	41.09x	6.89x	19.39x	1.9%	676B
ABBVIE INC.	37.85x	8.58x	17.73x	2.35%	519B
ROCHE HOLDING AG	21.6x	5.24x	13.12x	2.49%	388B
MERCK & CO., INC.	105.09x	5.99x	25.53x	2.29%	365B
NOVARTIS AG	23.85x	5.92x	14.34x	2.69%	307B
ASTRAZENECA PLC	24.15x	4.85x	13.63x	1.8%	287B
AMGEN INC.	24x	7.37x	13.6x	2.17%	252B
GILEAD SCIENCES, INC.	-40.15x	7.43x	46.76x	1.93%	212B
Average	35.28x	7.62x	22.29x	1.87%	430B
Weighted average by Cap.	37.40x	8.89x	22.62x	1.68%